Christine Granfield - Mar 31, 2023 Form 4 Insider Report for LEAP THERAPEUTICS, INC. (LPTX)

Signature
/s/ Douglas E. Onsi, as attorney-in-fact for Christine Granfield
Stock symbol
LPTX
Transactions as of
Mar 31, 2023
Transactions value $
$0
Form type
4
Date filed
4/4/2023, 08:15 PM
Previous filing
Sep 2, 2022
Next filing
Aug 25, 2023

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Underlying Class Amount Exercise Price Ownership Footnotes
transaction LPTX Employee Stock Option (Right to Buy) Award $0 +500K $0.00 500K Mar 31, 2023 Common Stock 500K $0.34 Direct F1
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 The Option was granted pursuant to Leap's 2016 Equity Incentive Plan. By its terms, the Option shall vest and become exercisable for the shares underlying the Option in a series of 36 equal monthly installments for so long as the reporting person continues to be employed by or provides service to the Company, with the first of such monthly installments vesting on the one month anniversary of March 31, 2023, the Vesting Start Date.